Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms26010166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Maciej Skrzypczak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Gynecology, Medical University of Lublin, 20-954 Lublin, Poland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Epigenesis, Genetic, Signal Transduction, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ovarian cancer remains one of the leading causes of cancer-related deaths in women. There are several processes that are described to have a causal relationship in ovarian cancer development, progression, and metastasis formation, that occur both at the genetic and epigenetic level. One of the mechanisms involved in its pathogenesis and progression is estrogen signaling. Estrogen receptors (ER) α, ERβ, and G-protein coupled estrogen receptor 1 (GPER1), in concert with various coregulators and pioneer transcription factors, mediate the effects of estrogens primarily by the transcriptional regulation of estrogen responsive genes, thereby exerting pleiotropic effects including the regulation of cellular proliferation and apoptosis. The expression and activity of estrogen receptors and their coregulators have been demonstrated to be regulated by epigenetic mechanisms like histone modifications and DNA methylation. Here, we intend to summarize and to provide an update on the current understanding of epigenetic mechanisms regulating estrogen signaling and their role in ovarian cancer. For this purpose, we reviewed publications on this topic listed in the PubMed database. Finally, we assess to which extent drugs acting on the epigenetic level might be suitable for the treatment of ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Gynecology, Medical University of Lublin, 20-954 Lublin, Poland.
- Department of Pathology, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Clinic of Infectious Diseases, University of Life Sciences Lublin, 20-950 Lublin, Poland.
- Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93935 Regensburg, Germany.
ORCID-Profile: Oliver Treeck
Zitieren
APA
Skrzypczak, M., Wolinska, E., Adaszek, Ł., Ortmann, O., & Treeck, O. (2024). Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010166
Vancouver
Skrzypczak M, Wolinska E, Adaszek Ł, Ortmann O, Treeck O. Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010166
BibTeX
@article{Skrzypczak2024,
author = {Skrzypczak, Maciej and Wolinska, Ewa and Adaszek, Łukasz and Ortmann, Olaf and Treeck, Oliver},
title = {Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms26010166}
}
EUVIMED